IIIA 병기의 비소세포 폐암 환자에서 술전 유도화학요법의 임상적 효과

Background: Surgical therapy remains the only curative treatment of localized non-small cell lung cancer(NSCLC). But the efficacy of surgery for patients with NSCLC is limited, although recent studies suggest that neoadjuvant chemotherapy may improve survival. Many studies also demonstrated benefit...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Korean journal of medicine 1999-08, Vol.57 (2), p.183
Hauptverfasser:	정성수, Seong Su Jeong, 강동원, Dong Won Kang, 이규승, Gyu Seung Lee, 고동석, Dong Seok Ko, 서재철, Jae Chul Suh, 김근화, Geun Hwa Kim, 김주옥, Ju Ock Kim, 김선영, Sun Young Kim
Format:	Artikel
Sprache:	kor
Schlagworte:	Neoadjuvant chemotherapy Non-small cell lung cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!